- Propanc Biopharma (NASDAQ:PPCB) announced on Wednesday a strategic financing agreement of up to $100M with Hexstone Capital.
- Shares were +2.81% pre-market to $1.83.
- Propanc is set to issue 100 shares of newly designated series C convertible preferred stock, each with a
#Propanc #Biopharma #announces #100M #strategic #financing #Hexstone #Capital #PPCBNASDAQ